Results 361 to 370 of about 3,376,929 (374)
Some of the next articles are maybe not open access.

Resistance to Antifungal Drugs

2003
Abstract Fungal infections caused by fungal pathogens remain quite common in immunocompromised hosts, especially in HIV-infected individuals, and in patients given immunosuppressive drugs or broad-spectrum antibiotics. Candida spp. represent the major group of yeast species recovered from these infected individuals; however, other yeasts
openaire   +1 more source

Antifungal Resistance: An Emerging Battlefield

Future Microbiology, 2020
Patrick Cy, Woo   +2 more
openaire   +2 more sources

Mechanisms of antifungal resistance.

Revista iberoamericana de micologia, 2007
The many drugs that are available at present to treat fungal infections can be divided into four broad groups on the basis of their mechanism of action. These antifungal agents either inhibit macromolecule synthesis (flucytosine), impair membrane barrier function (polyenes), inhibit ergosterol synthesis (allylamines, thiocarbamates, azole derivatives ...
openaire   +1 more source

Antifungal Resistance: Aspergillus

2009
P. H. Chandrasekar, Elias K. Manavathu
openaire   +1 more source

Antifungal Drug Resistance

2009
Pranab Mukherjee, Mingyue Wang
openaire   +1 more source

Antifungal resistance discussed

Inpharma Weekly, 2002
openaire   +1 more source

The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses

American Journal of Clinical Dermatology, 2020
Aditya K. Gupta   +4 more
semanticscholar   +1 more source

Antifungal drug resistance

Journal of the European Academy of Dermatology and Venereology, 1995
openaire   +1 more source

Home - About - Disclaimer - Privacy